openPR Logo
Press release

Finding Opportunities in the Generic Neurology Drug Sector

07-26-2017 01:32 PM CET | Health & Medicine

Press release from: Applied Market Data

(Nashua, NH) – In terms of medical specialty segments, neurology represents one of the broadest and deepest drug therapy markets. The convergence of evolution in healthcare technology and refinements in prescribing trends for non-pathological conditions continue to advance this segment. It has been and continues to be one of the two most active medical specialties for generic drug marketers.

Currently the generic neurology drug sector is comprised of 203 APIs representing 40 therapeutic classes. These drugs are supported by 2,380 unique ANDAs. At the product dosage level, the number expands to a grand total of 6,900 unique generic drug products.

More than three hundred companies compete in the generic neurology segment. At the individual competitor level, about one-third of ANDA applicants account for at least ten generic neurology drug APIs. More than half of the suppliers in the generic neurology segment are listed as ANDA applicants for four APIs or fewer.

Our analysis into these numbers exposes the underlying product landscape and relative activity levels across therapeutic classes and reveals a number of segments that represent potential opportunities for generic drug suppliers. As expected, these classes are highly competitive with numerous suppliers. However, the competitive intensity at the dosage level demonstrates uneven competition. Successfully identifying dosage levels for specific generics that may be underserved and thus represent growth potential requires a comprehensive assessment of disease prevalence and prescribing trends, but can be an attractive option in the highly competitive neurology generics market.

These findings are contained in a comprehensive report researched and written by Applied Market Data. Generic Neurology Drugs has been researched and written to provide market participants and stakeholders with a comprehensive analysis of the products, therapeutic segments, competitive landscape and market scope in this evolving generic drug segment.

More information is available at www.appliedmarketdata.com


Source: Applied Market Data

About Applied Market Data

Applied Market Data is a consulting firm focused on the generic drug sector. We assist companies in achieving their business objectives through the creation of decision support information tools and market research and analysis. Our publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and achieve their financial targets.

Contact:

Greg Stone
Applied Market Data
98 Amherst Street
Amherst, NH 03031 USA
Voice: 603-341-3073
grstone@appliedmarketdata.com
www.appliedmarketdata.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Finding Opportunities in the Generic Neurology Drug Sector here

News-ID: 639035 • Views:

More Releases from Applied Market Data

Point-of-Care Vascular Visualization Devices Targeting Improved Access Success R …
(Nashua, NH) – As medical technology continues to advance and the number of invasive procedures grows, device developers and designers increasingly focus on patient-friendly products that address existing needs while improving patient acceptance and caregiver benefits. One of the most common procedural markets for commercially viable devices is peripheral vascular access. The ability of the caregiver to identify a suitable vein for IV insertion is a key performance factor that
Cyclic Olefin Use in Primary Containers Positioned to Grow as Initial Deployment …
(Nashua, NH) – Medical device manufacturers are gradually turning to new materials such as cyclic olefin polymers and copolymers (/COPs/COCs) for primary drug container applications. COCs and other new plastics offer high heat resistance and a low level of extractables and leachables, and are less permeable to water. Because of their inert surface and break resistance these syringes are considered suitable for use in the demanding area of cytostatics and
Hazards of Cytotoxic Drugs Spurring New Standards and Solutions
(Nashua, NH) – The use of drugs that must be handled with care to avoid collateral harm to patients and caregivers is receiving increased attention as new information on the risks becomes known. These drugs – cytotoxic drugs – are an important element in the treatment of numerous types of cancer and are also used at lower doses to treat autoimmune conditions. New standards that specify the way these drugs
Growth of Wearable Healthcare Devices Creating Opportunities for Specialty Adhes …
(Nashua, NH) – The miniaturization of electronics continues to drive innovation, enhanced patient care and improved outcomes throughout the healthcare industry. At the forefront of these advances are devices owing their feature functionality to the performance of a new generation of sensing elements and improved signal processing. This technology has spawned a new generation of products – wearable healthcare devices designed to be worn directly on the skin using pressure

All 5 Releases


More Releases for APIs

Global HP (High Potency) APIs Market | Global HP (High Potency) APIs Industry | …
The high potency APIs (HPAPI) market involves of sales of high potency energetic pharmaceutical ingredients and interrelated services. High potency APIs are tremendously effective in pharmacologically vigorous ingredients. These are exceedingly specific in their action and offer momentous efficiency even at the lower daily therapeutic doses. HPAPIs are utilized in formulations for great potent drugs, due to their ability to target precise syndrome cells involving the cancer cells. According to the
Global Platinum-based Anticancer APIs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Platinum-based Anticancer APIs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Platinum-based Anticancer APIs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure
Highly Potent APIs 2019 Conference: Interview with Bayer Pharma
Dr Ulrich Rüemenapp, Head of Launch Preparation and Coordination at Bayer Pharma, will be discussing late stage CMC development and bio-manufacturing for fast track projects at SMi’s 3rd annual Highly Potent Active Pharmaceutical Ingredients conference. Ahead of the conference next month, SMi interviewed him where he gave his thoughts on how the industry has progressed and what the future holds for the industry. Ulrich said: “From my point of view the hype
API Management Market - Rise In The Popularity of Web APIs
The need to manage the usage of application programming interfaces (APIs) to decode the data of systems or enterprises in a bid to make it usable for other sections of the organization or for third-party organizations in novel ways is boosting the global API management market. The rising need for the governance and a life-cycle framework for APIs is also fueling the demand for API management solutions, which is reflecting
Global Konjac Glucomannan Market 2018- APIS, AuNutra, Shaanxi Top Pharm
Apex Market Reports, recently published a detailed market research study focused on the "Global Konjac Glucomannan Market" across the global, regional and country level. The report provides 360° analysis of "Global Konjac Glucomannan Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the Global Konjac Glucomannan industry, and estimates the future trend of Global
Biotech APIs Showing Insurgent Growth
According to a new research report by RNCOS entitled, “Global Biotech API Market Analysis”, the rapidly growing and innovating biopharmaceuticals and biotechnology industry as a whole is putting the biotech API industry into charts of insurgent growth. Research Analysis & Highlights The report, “Global Biotech API Market Analysis”, spread over 55 pages, provides an in-depth research and rational analysis of the current and expected status of the biotech API industry across the